Cartesian Therapeutics, Inc. (RNAC)
6.35
-0.54
(-7.84%)
USD |
NASDAQ |
May 19, 14:12
Cartesian Therapeutics Research and Development Expense (Quarterly) : 19.46M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insmed, Inc. | 209.48M |
| Regeneron Pharmaceuticals, Inc. | 1.420B |
| Precision BioSciences, Inc. | 12.83M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |
| Alnylam Pharmaceuticals, Inc. | 364.87M |